130A — Veritas in Silico Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Veritas in Silico, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1,689	1,484	1,549	2,173
Net Total Accounts Receivable
Net Total Receivables	4.33	35.8	59.1	21
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,729	1,547	1,629	2,232
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.4	47.7	23.6	14.1
Net Intangible Assets
Other Long Term Assets
Total Assets	1,755	1,599	1,656	2,249
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	70.8	56	79.9	39.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	70.8	56	79.9	39.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,684	1,543	1,576	2,210
Total Liabilities & Shareholders' Equity	1,755	1,599	1,656	2,249
Total Common Shares Outstanding